Carnosic acid promotes degradation of the androgen receptor and is regulated by the unfolded protein response pathway in vitro and in vivo

In conclusion, these data suggest that molecules such as carnosic acid could be further evaluated and optimized as a potential therapeutic alternative to target AR in prostate cancer.

Source: Carcinogenesis - July 29, 2016 Category: Cancer & Oncology Authors: Petiwala, S. M., Li, G., Bosland, M. C., Lantvit, D. D., Petukhov, P. A., Johnson, J. J. Tags: Original Manuscript Source Type: research